In this scenario, the assessment of inflammatory markers in individuals at risk of dementia may reflect a more robust diagnostic measure and the conduct of this research aimed to seek evidence of the diagnostic accuracy parameters of cytokines (IL-6, IL-10 and TNF-α) to resolve doubts and complement the detection of MCI, thus providing support in clinical decision making. The gene discussed is IL6; the disease is dementia.